PEARW Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	470 418
Vidutinė apimtis	0
Rinkos kapitalizacija	0.00
EPS	$0.210 ( Q4 \| 2023-03-31 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 31.08
ATR14	$0.0240 (406.78%)

ACONW 13.35%

AKLI -0.07%

BEATW -10.00%

BFRG -1.14%

BFRGW -12.15%

BTSG 4.99%

BTSGU 5.87%

CCLD -3.52%

CCLDO 3.02%

CCLDP -0.98%

CERN 0.00%

CHNG 0.26%

CMAXW -6.00%

ETAO -31.79%

EUDA -26.38%

EUDAW 16.53%

GEHC -1.14%

GEHCV -4.08%

INOV 0.14%

KERNW 0.00%

LIFW -2.17%

MGRX -5.88%

MSPR 0.00%

MSPRV -11.57%

MSPRW 0.00%

MSPRZ 0.00%

MTBC 12.19%

MTBCO 0.16%

MTBCP -0.28%

ONMD -1.75%

OTRKP 10.34%

PEARW 0.00%

SHCRW -3.26%

SHLT -5.62%

Insider Trading

Date	Person	Action	Amount	type
2023-04-10	5am Partners Iv, Llc	Sell	3 172 769	Class A Common Stock
2023-04-10	5am Partners Iv, Llc	Sell	534 855	Class A Common Stock
2023-02-15	Snow Ellen	Buy	199 864	Restricted Stock Units
2023-02-16	Snow Ellen	Buy	40 000	Restricted Stock Units
2023-02-15	Brenner Erin K.	Buy	952 380	Restricted Stock Units

INSIDER POWER
33.30
Last 93 transactions
Buy: 32 556 402 \| Sell: 10 288 531

Tūris Koreliacija

Ilgas: -0.42 (neutral)

Trumpas: -0.95 (very strong negative)

Signal:(33.773) Neutral

Pear Therapeutics, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Pear Therapeutics, Inc. Koreliacija - Valiuta/Žaliavos

0.42
( neutral )

-0.69
( moderate negative )

0.00
( neutral )

0.45
( neutral )

0.57
( weak )

-0.29
( neutral )

Pear Therapeutics, Inc. Finansinės ataskaitos

Annual	2022
Pajamos:	$12.69M
Bruto pelnas:	$4.51M (35.54 %)
EPS:	$-0.170

FY	2022
Pajamos:	$12.69M
Bruto pelnas:	$4.51M (35.54 %)
EPS:	$-0.170

FY	2021
Pajamos:	$4.21M
Bruto pelnas:	$-1.03M (-24.36 %)
EPS:	$0

Financial Reports:

No articles found.

Pear Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Pear Therapeutics, Inc.

Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.